glp-1 medications in weight management The revolution: What UAB researchers are discovering about how these drugs work Chart: 1 in 8 Americans

Participants with the highest body mass index (BMI) values (40 or above) were most likely to access semaglutide, which is not surprising given that this group has the highest risk for developing further metabolic diseasebut Podolsky says it reflects a trend that physicians may be restricting GLP-1 drugs to patients with the highest weight, and solely recommending lifestyle interventions to patients with BMI values of 35 or less

Gut microbiota: the link to your second brain

The benefits can be impressive, but they usually depend on consistency over time

doi: 10.1016/j.cmet.2021.01.015 42

Why this suits women: Hormonal shifts during perimenopause and menopause redirect fat storage toward the abdominal compartment through declining estrogen, increasing cortisol sensitivity, and reduced growth hormone output

The above study from Diabetes Obesity Metabolism said: The average change in body weight was similar in the two groups (-3.7 kg with injectable and -3.3 kg with oral at 18 months), but more new users of injectable semaglutide lost 5% body weight. According to Dr